A Case of Hemolytic Uremic Syndrome after Transarterial Chemoembolization with Cisplatin / 대한내과학회지
Korean Journal of Medicine
;
: 67-72, 2013.
Artículo
en Coreano
| WPRIM
| ID: wpr-53546
ABSTRACT
Hemolytic uremic syndrome (HUS) is a rare disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. These characteristics are related to the formation of platelet-rich microthrombi in the microvasculature. HUS is associated with a variety of etiologies, including cisplatin. Previously reported HUS cases after cisplatin administration were almost always related to systemic combination chemotherapy that included cisplatin. Transarterial chemoembolization (TACE) is commonly used in treatment of hepatocellular carcinoma, and most centers in Korea use cisplatin. A 70-year-old female with hepatocellular carcinoma was treated with TACE including cisplatin and subsequently developed clinical and laboratory findings compatible with HUS.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Trombocitopenia
/
Cisplatino
/
Quimioembolización Terapéutica
/
Carcinoma Hepatocelular
/
Quimioterapia Combinada
/
Microvasos
/
Lesión Renal Aguda
/
Síndrome Hemolítico-Urémico
/
Anemia Hemolítica
/
Corea (Geográfico)
Límite:
Femenino
/
Humanos
País/Región como asunto:
Asia
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS